ATE284697T1 - Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen - Google Patents

Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen

Info

Publication number: ATE284697T1
Authority: AT; Austria
Prior art keywords: rhamnolipid; pharmaceutical preparation; dermatological diseases; preparation based; mono
Prior art date: 1992-02-04

Application number

AT93914523T

Other languages

English (en)

Inventor

Goran Piljac

Visnja Piljac

Original Assignee

Paradigm Biomedical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-04

Filing date

1993-02-04

Publication date

2005-01-15

1993-02-04 Application filed by Paradigm Biomedical Inc filed Critical Paradigm Biomedical Inc

2005-01-15 Application granted granted Critical

2005-01-15 Publication of ATE284697T1 publication Critical patent/ATE284697T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Virology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Immunology (AREA)
Zoology (AREA)
General Engineering & Computer Science (AREA)
Oncology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Biochemistry (AREA)
Communicable Diseases (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Pulmonology (AREA)
Birds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Cosmetics (AREA)

AT93914523T 1992-02-04 1993-02-04 Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen ATE284697T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
BE9200115A BE1005704A4 (nl)	1992-02-04	1992-02-04	Farmaceutisch preparaat op basis van rhamnolipide.
US86669192A	1992-04-10	1992-04-10
PCT/EP1993/000270 WO1993014767A2 (en)	1992-02-04	1993-02-04	Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections

Publications (1)

Publication Number	Publication Date
ATE284697T1 true ATE284697T1 (de)	2005-01-15

Family

ID=25662615

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93914523T ATE284697T1 (de)	1992-02-04	1993-02-04	Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen

Country Status (11)

Country	Link
EP (1)	EP0630252B1 (de)
JP (2)	JP3860206B2 (de)
AT (1)	ATE284697T1 (de)
AU (1)	AU3453493A (de)
BE (1)	BE1005704A4 (de)
CA (1)	CA2129542C (de)
DE (1)	DE69333723T2 (de)
DK (1)	DK0630252T3 (de)
ES (1)	ES2235155T3 (de)
PT (1)	PT630252E (de)
WO (1)	WO1993014767A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5466675A (en) *	1992-02-04	1995-11-14	Piljac; Goran	Immunological activity of rhamnolipids
JP2002504513A (ja) *	1998-02-24	2002-02-12	タトジャナ・ピルジャック	傷の治癒、火傷のショックの治療、アテローム性動脈硬化症、器官移植、鬱病、精神分裂病、及び化粧品におけるラムノリピドの使用
EP1889623A3 (de) *	1998-02-24	2009-04-08	Paradigm Biomedical Inc.	Verwendung von Rhamnolipiden für die Wundheilung, für die Behandlung von Verbrennungen, Arteriosklerose, Organtransplantationen, Depressionen und Schizophrenie sowie für Kosmetikartikel
DE60044674D1 (de) *	1999-08-05	2010-08-26	Paradigm Biomedical Inc	Verwendung von rhamnolipiden zur wundheilung, behaund periodontaler regeneration
US20040242501A1 (en) *	2003-03-20	2004-12-02	Gross Richard A.	Spermicidal and virucidal properties of various forms of sophorolipids
DE102005052210A1 (de) *	2005-10-26	2007-05-03	Südzucker Aktiengesellschaft Mannheim/Ochsenfurt	Mikrobiologisch stabilisiertes Bier
WO2008013899A2 (en) *	2006-07-27	2008-01-31	Aurora Advance Beauty Labs	Rhamnolipid-based formulations
DK2648742T3 (da)	2010-12-09	2019-07-15	Y&B Mothers Choice Ltd	Formuleringer indeholdende saponiner og anvendelser deraf
DK2648809T3 (da)	2010-12-09	2019-07-15	Y&B Mothers Choice Ltd	Naturlige formuleringer
US10434058B2 (en)	2010-12-09	2019-10-08	Y&B Mother's Choice Ltd.	Natural formulations
DE102012221519A1 (de)	2012-11-26	2014-05-28	Evonik Industries Ag	Verfahren zur Isolierung von Rhamnolipiden
DE102013205756A1 (de)	2013-04-02	2014-10-02	Evonik Industries Ag	Mischungszusammensetzung enthaltend Rhamnolipide
EP2786742A1 (de) *	2013-04-02	2014-10-08	Evonik Industries AG	Kosmetika enthaltend Rhamnolipide
IL229836A0 (en)	2013-12-08	2014-03-31	Y & B Mother S Choice Ltd	Formulations to reduce or suppress irritation to eye tissue
CN106794200A (zh) *	2014-06-20	2017-05-31	生物科技联合中心	包含具有抗菌及防腐活性的绿脓杆菌培养液提取物的组合物及其的用途
EP3338762A1 (de) *	2016-12-22	2018-06-27	L'oreal	Verwendung von rhamnolipid zur behandlung von hautrötung
US20240016717A1 (en) *	2020-08-28	2024-01-18	L Oreal	Composition comprising glycolipid and salicylic acid derivative
EP4015588A1 (de) *	2020-12-15	2022-06-22	Evonik Operations GmbH	Verwendung von rhamnolipiden und/oder sophorolipiden in beschichtungszusammensetzungen zur erhaltung eines homogenen farbbildes des trockenen beschichtungsfilms und/oder zur erhöhung der arbeitssicherheit bei der herstellung von beschichtungszusammensetzungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4814953B1 (de) *	1970-10-14	1973-05-11
JPS60183032A (ja) *	1984-03-02	1985-09-18	Shiseido Co Ltd	乳化組成物
DD248279A1 (de) *	1984-09-07	1987-08-05	Univ Leipzig	Antiphytovirale therapie mit biogenen mitteln
JPS6377533A (ja) *	1986-09-18	1988-04-07	Fujitsu Ltd	減圧処理装置の圧力切り替え方法
JPS63253025A (ja) *	1987-04-09	1988-10-20	Yamanouchi Pharmaceut Co Ltd	ホスホリパ−ゼａ↓２阻害剤
FR2645741B1 (fr) *	1989-03-20	1995-06-23	Dior Christian Parfums	Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation

1992
- 1992-02-04 BE BE9200115A patent/BE1005704A4/nl not_active IP Right Cessation
1993
- 1993-02-04 WO PCT/EP1993/000270 patent/WO1993014767A2/en active IP Right Grant
- 1993-02-04 EP EP93914523A patent/EP0630252B1/de not_active Expired - Lifetime
- 1993-02-04 CA CA002129542A patent/CA2129542C/en not_active Expired - Fee Related
- 1993-02-04 DK DK93914523T patent/DK0630252T3/da active
- 1993-02-04 AU AU34534/93A patent/AU3453493A/en not_active Abandoned
- 1993-02-04 JP JP51294693A patent/JP3860206B2/ja not_active Expired - Fee Related
- 1993-02-04 DE DE69333723T patent/DE69333723T2/de not_active Expired - Lifetime
- 1993-02-04 PT PT93914523T patent/PT630252E/pt unknown
- 1993-02-04 AT AT93914523T patent/ATE284697T1/de not_active IP Right Cessation
- 1993-02-04 ES ES93914523T patent/ES2235155T3/es not_active Expired - Lifetime
2004
- 2004-01-05 JP JP2004000631A patent/JP2004149547A/ja active Pending

Also Published As

Publication number	Publication date
CA2129542C (en)	2008-04-22
CA2129542A1 (en)	1993-08-05
EP0630252B1 (de)	2004-12-15
WO1993014767A2 (en)	1993-08-05
JPH09503196A (ja)	1997-03-31
EP0630252A1 (de)	1994-12-28
JP2004149547A (ja)	2004-05-27
JP3860206B2 (ja)	2006-12-20
ES2235155T3 (es)	2005-07-01
AU3453493A (en)	1993-09-01
BE1005704A4 (nl)	1993-12-21
WO1993014767A3 (en)	1993-09-02
DK0630252T3 (da)	2005-04-04
DE69333723D1 (de)	2005-01-20
PT630252E (pt)	2005-04-29
DE69333723T2 (de)	2005-12-08

Publication	Publication Date	Title
ATE284697T1 (de)	2005-01-15	Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen
NO950297D0 (no)	1995-01-26	Prolinamidderivater
DK0490667T3 (da)	1999-12-13	HIV-proteaseinhibitorer
HUP0101999A2 (hu)	2001-11-28	4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
RU94041223A (ru)	1996-10-20	Средство для лечения мотонейроновых заболеваний
NO963053D0 (no)	1996-07-22	Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
DE69206876D1 (de)	1996-02-01	Nukleosidanalogen enthaltende Antiviren-Zubereitungen
ES2148254T3 (es)	2000-10-16	Peptidos antimicrobianos ciclicos y preparacion de los mismos.
FI922044A0 (fi)	1992-05-06	Ny polypeptid och daerav framstaelld hiv-medicin.
ES2051834T3 (es)	1994-07-01	El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
KR970705563A (ko)	1997-10-09	항바이러스제로서의 4-(2-아미노-6-(시클로프로필아미노)-9H-푸린-9-일)-2-시클로펜텐-1-메탄올 숙시네이트(4-(2-Amino-6-(Cyclopropylamino)-9H-Purin-9-yl)-2-Cyclopentene-1-Methanol Succinate as Antiviral Agent)
KR890005088A (ko)	1989-05-11	4- 아미노피리딘 유도체 및 그의 산 부가염
DE68923169D1 (de)	1995-07-27	Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
KR910004191A (ko)	1991-03-28	신질환치료제
FI911875A0 (fi)	1991-04-18	Kirala 2-(fosfonometoxi) propylguaniner som antivirala aemnen.
MX9206930A (es)	1993-06-01	Nuevos compuestos
BR9306870A (pt)	1998-12-08	Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
ATE86117T1 (de)	1993-03-15	Zusammensetzung gegen leberkrankheiten.
KR930016417A (ko)	1993-08-26	피롤릴벤조디아제핀온
ES2169117T3 (es)	2002-07-01	Uso de derivados de 2-aminopurina en el tratamiento y profilaxis de la infeccion por el virus 7 del herpes humano.
DK165967C (da)	1993-07-26	Anvendelse af en 2-oxo-imidazolidinforbindelse til fremstilling af et farmaceutisk praeparat
NO903585L (no)	1991-02-18	Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.
DK653687D0 (da)	1987-12-11	Middel til behandling af nyresygdomme
EP0653207A4 (de)	1995-03-06	Aids-virus-infektion hemmende zusammensetzung.
KR960037045A (ko)	1996-11-19	B형 바이러스(hbv)성 간염의 예방 및 치료용 약학적 제제

Legal Events

Date	Code	Title	Description
2005-09-15	UEP	Publication of translation of european patent specification	Ref document number: 0630252 Country of ref document: EP
2011-11-15	REN	Ceased due to non-payment of the annual fee

Date

Code

Title

Description

2005-09-15

UEP

Publication of translation of european patent specification

Ref document number: 0630252

Country of ref document: EP

2011-11-15

REN

Ceased due to non-payment of the annual fee